Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Early research (Phase 1)Looking for participantsNCT06821464
What this trial is testing

A Trial of HRS-9813 in Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis
Guangdong Hengrui Pharmaceutical Co., Ltd 60
Testing effectiveness (Phase 2)Looking for participantsNCT06714123
What this trial is testing

Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease

Who this might be right for
Pulmonary Fibrosis, Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Vejle Hospital 140
Not applicableStudy completedNCT05875532
What this trial is testing

Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 34,960
Not applicableUnknownNCT05450276
What this trial is testing

Patient-Reported Outcome Study of Project ECHO for ILD

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 56
Testing effectiveness (Phase 2)Study completedNCT02594839
What this trial is testing

Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease

Who this might be right for
Idiopathic Interstitial PneumoniaInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia 20
Testing effectiveness (Phase 2)Study completedNCT04308681
What this trial is testing

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

Who this might be right for
Pulmonary Fibrosis
Bristol-Myers Squibb 403
Not applicableLooking for participantsNCT07332117
What this trial is testing

A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis
Royal Brompton & Harefield NHS Foundation Trust 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05828953
What this trial is testing

Anlotinib Capsules in the Treatment for IPF/PF-ILDs

Who this might be right for
Interstitial Lung Diseases
First Affiliated Hospital of Wenzhou Medical University 30
Large-scale testing (Phase 3)Enrolling By InvitationNCT04905693
What this trial is testing

Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

Who this might be right for
Idiopathic Pulmonary FibrosisInterstitial Lung DiseaseProgressive Pulmonary Fibrosis
United Therapeutics 1,850
Testing effectiveness (Phase 2)Looking for participantsNCT06951217
What this trial is testing

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

Who this might be right for
Progressive Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF)
Avalyn Pharma Inc. 340
Not applicableUnknownNCT05445817
What this trial is testing

Pulmonary Care and Research Collaborative Patient Registry

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 150
Not applicableLooking for participantsNCT01915511
What this trial is testing

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Who this might be right for
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Duke University 3,000
Post-approval studies (Phase 4)Study completedNCT03939520
What this trial is testing

Management of Progressive Disease in Idiopathic Pulmonary Fibrosis

Who this might be right for
Progressive Idiopathic Pulmonary Fibrosis
Hospices Civils de Lyon 279
Not applicableLooking for participantsNCT06162884
What this trial is testing

Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
University of California, Los Angeles 200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07441408
What this trial is testing

Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
Bristol-Myers Squibb 2,277
Not applicableLooking for participantsNCT06644144
What this trial is testing

P4O2 ILD Extension

Who this might be right for
Interstitial Lung DiseasePulmonary FibrosisInterstitial Lung Fibrosis+7 more
Amsterdam UMC, location VUmc 450
Not applicableStudy completedNCT06200714
What this trial is testing

A Study Based on Medical Records in Spain That Looks at Diarrhoea Control in People With Pulmonary Fibrosis Who Are Taking Nintedanib

Who this might be right for
Idiopathic Pulmonary FibrosisDiarrhoea
Boehringer Ingelheim 18
Testing effectiveness (Phase 2)Looking for participantsNCT07572383
What this trial is testing

Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis

Who this might be right for
Interstitial Lung DiseasePulmonary Fibrosis
Peter Caravan 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT05241275
What this trial is testing

Xenon MRI and Progressive ILD

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis
Duke University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06422884
What this trial is testing

Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Fibrosing Interstitial Lung Disease
Endeavor Biomedicines, Inc. 213
Load More Results